awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33422258-FCDC0A44-0011-4D19-AB20-6CA736BE2821
Q33422258-FCDC0A44-0011-4D19-AB20-6CA736BE2821
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-FCDC0A44-0011-4D19-AB20-6CA736BE2821
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
P2860
Q33422258-FCDC0A44-0011-4D19-AB20-6CA736BE2821
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-FCDC0A44-0011-4D19-AB20-6CA736BE2821
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27b269ef3ab22a069302766eacd99fb1ffaa42c5
P2860
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.